Avid Bioservices Inc (CDMO)

[freethemice]

Bob, 5.6 months is on the low side, but nothing abnormal about it. There was a phase III trial with 5.7 months for a control
arm of docetaxel only. 5.6 months is about 1.5 standard deviations from the mean of these 14 trials. On the low side,
but not totally out there. If it was lower than that I expect it was not by much. Notice that both trials had 90% metastatic patients.